Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 1 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Biomemory America LLC currently has 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This matter is assigned to 1 distinct examiner, SCHULTZHAUS, JANNA NICOLE, who is the busiest examiner with 1 pending application. The portfolio is active in 1 distinct art unit, which indicates a narrow technical focus for the company's current filings.
With 1 pending office action, the company's current prosecution effort is highly concentrated. The assignment to 1 distinct examiner, SCHULTZHAUS, JANNA NICOLE, means that the company's immediate patent goals are subject to the review of a single individual. This 1 to 1 ratio between pending actions and art units indicates that the company is pursuing a specific technical path within the Biotechnology & Pharmaceuticals sector.
For practitioners, managing 1 pending office action under 1 distinct examiner requires a focused administrative approach. The success of the portfolio depends on the 1 pending application handled by SCHULTZHAUS, JANNA NICOLE. By addressing the requirements of the 1 distinct art unit, the company can effectively progress its intellectual property goals in this specialized technology area.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| NGUYEN, HENRY H | 1 | 63.7% | +37.2% |
| SCHULTZHAUS, JANNA NICOLE | 1 | 35.1% | +37.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17693705 | PROGRAMS AND FUNCTIONS IN DNA-BASED DATA STORAGE | SCHULTZHAUS, JANNA NICOLE | 30d overdue |
| 18027524 | TEMPERATURE-CONTROLLED FLUIDIC REACTIONS SYSTEM | NGUYEN, HENRY H | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17693705 | PROGRAMS AND FUNCTIONS IN DNA-BASED DATA STORAGE | SCHULTZHAUS, JANNA NICOLE | 30d overdue |
| 18027524 | TEMPERATURE-CONTROLLED FLUIDIC REACTIONS SYSTEM | NGUYEN, HENRY H | — |
| Art Unit | Apps |
|---|---|
| 1685 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18027524 | TEMPERATURE-CONTROLLED FLUIDIC REACTIONS SYSTEM | NGUYEN, HENRY H | — | §102§103§112 | Non-Final OA | — | Pending | Feb 12, 2024 |
| 17693705 | PROGRAMS AND FUNCTIONS IN DNA-BASED DATA STORAGE | SCHULTZHAUS, JANNA NICOLE | 1685 | §102§103§112 | Final Rejection | 30d overdue | Pending | Mar 14, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial